Xuezhikang, a Chinese traditional medicine, contains natural statin and is effective on dyslipidemia by inhibiting cholesterol synthesis. Xuezhikang therapy for 8 weeks in patients with hyperlipidemia reduced total cholesterol (TC) by 23％, low density lipoprotein cholesterol (LDL-C) by 28.5％and triglyceride(TG) by 36.5％ , and increased high density lipoprotein cholesterol (HDL-C) by 19.6％ , respectively. Data from China Coronary Secondary Prevention Study (CCSPS) showed that treatment with Xuezhikang lowered the risks of major coronary events, death from coronary heart disease, and all cause death in patients with myocardial infarction, indicating that Xuezhikang can be used in the primary and secondary prevention of cardiovascular disease.

作者：中国老年学和老年医学学会心脑血管病专业委员会；血脂康(胶囊)临床应用中国专家共识组

来源：中华内科杂志 2018 年 57卷 2期